期刊文献+

The Type of Catalyst to Physical Properties of Soy-Based Polyurethane

The Type of Catalyst to Physical Properties of Soy-Based Polyurethane
在线阅读 下载PDF
导出
摘要 Flexible Polyurethane (PU) foam is the material most widely used among urethanes. The foams were synthesized via the reaction of soy polyol, mixtures of isocyanates MDI:TDI (80:20), in the presence of water (blowing agent) with molding process. This experiment was to analyze the physical properties of soy polyol and elaborate the principle of catalyst within the synthesis. The use of liquid and solid catalyst on the polyol synthesis results in significant cellular morphology and properties of polyurethane foam. It is found that the PU which was synthesized using bentonite catalyst has an irregular form of cell morphology, and it has higher density than using sulphuric acid catalyst.
出处 《Journal of Chemistry and Chemical Engineering》 2012年第1期96-100,共5页 化学与化工(英文版)
关键词 Soy polyol CATALYST POLYURETHANE ISOCYANATE morphology. 合成催化剂 聚氨酯泡沫 物理性质 大豆 聚醚多元醇 质型 基础 泡沫塑料
  • 相关文献

参考文献11

  • 1沙瑞娟,赵翕平,刘琳.尿毒症的神经系统表现(附3例报告)[J].脑与神经疾病杂志,2001,9(4):225-226. 被引量:6
  • 2Reichel, C. J; Fishback, T. L.; Aviles, G. Low Unsaturation Polyoxyalkylene Polyether Polyols. EP 0781791, 1977.
  • 3Laycock, D.; Sewell, R. Process for the Preparation of Polyether Polyols with Reduced Unsaturation Content. US Patent 5,374,705, 1994.
  • 4Cattaneo M. Hyperhomocysteinemia,atheroclosis and thrombosis[J]. Thromb Hae most,1999,81(2):165-176.
  • 5Milliken, T. K.; Miles, G. A.; Oblad, A. D. Trans. FaradaySoc. 1950, 8, 279-290.
  • 6刘建珍,曹传洲,赵钧和,傅善基,包承梅,毕大鹏,嵇高德.脑梗死患者血清同型半胱氨酸变化及机制的探讨[J].中风与神经疾病杂志,2003,20(4):295-298. 被引量:19
  • 7杨凌,胡敏燕,侯凡凡,陈彤.尿毒症患者血浆同型半胱氨酸水平测定[J].中国药学杂志,2003,38(3):201-203. 被引量:2
  • 8Herrington, R.; Hock, K. Flexiblr Polyurethane foams, 2nded; The Dow Chem. Co.: Midland, MI, 1998.
  • 9Eikelboom JW,Hankey GJ,Anard SS,et al. Association between high homocysteine and ischemic stroke due to large-and small-artery disease but not other etiolical subtype of ischemic stroke[J]. Stroke,2000,31:1069-1075.
  • 10Massy ZA,Ceballos I,Chadefaux-Vekemens B,et al. Homocysteine,oxidative Stress,and endothelium function in uremic patients[J]. Kideny Int Suppi,2001,78:243-245.

二级参考文献11

  • 1[1]Coull BM, Malionow MR, Beamer N ,et al. Elevated plasma homocysteine concentration as a possible independent risk factor for stroke[J]. Stroke, 1990,21:572-576.
  • 2[2]Houston PE,Rana S, Sekhsaria S,et al. Homocysteine in sickle cell disease:relationship to stroke[J]. Am J Med, 1997,103:192-196.
  • 3[3]Yoo JH,Chung CS,Kang SS. Relation of plasma homocysteine to cerebral infarction and cerebral atheriosclerosis[J]. Stroke,1998,29(12) :2478-2483.
  • 4[4]Heijer M,Blom HJ,Gorrits WBJ,et al. Is hyperhomocysteinemia a risk factor for recurrent venous thrombosis [J]. Lancet, 1995,345:882-889.
  • 5[5]Motulsky AG. Nutritional ecogenetics:homocysteine-related arteriosclerotic vascular disease, neural tube defects, and folic acid[J]. Am J Hum Genet,1996,58:17-21.
  • 6[6]Tsai MY,Hanson NQ,Schwichtenberg K,et al. Amplification refractory mutation system to identify mutations in cystathionine β-synthase deficiency[J]. Clin Chem, 1995,41:1775-1776.
  • 7[7]Franken DG,Boers GH,Blom HJ,et al. Treatment of mild hyperhomocysteinemia in vascular disease patients [J]. Arterioscler Thromb, 1994,14 :465-470.
  • 8[8]Glueck CJ,Shaw P,Lang JE,et al. Evidence that homocysteine is anoindependent risk factor for atheriosclerosis in hyperlipidemic patients[J]. Am J Cardiol, 1995,75:132-136.
  • 9廖杰芳,徐评议.肾衰时神经肌肉系统并发症的诊治[J].临床神经病学杂志,1989,2(3):136-137. 被引量:1
  • 10许海燕.高同型半胱氨酸血症与冠心病研究进展[J].现代诊断与治疗,1999,10(3):156-158. 被引量:27

共引文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部